Akebia Therapeutics shares owned by Barclays
Quarter-by-quarter ownership of Akebia Therapeutics (AKBA) shares owned by Barclays
from 13F filings
Historical chart of Barclays investment in Akebia Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Akebia Therapeutics held by Barclays consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Akebia Therapeutics by Barclays
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $3.2M | 1.2M | 2.73 |
| 2025-06-30 | $3.6M | 985k | 3.64 |
| 2025-03-31 | $591k | 308k | 1.92 |
| 2024-12-31 | $713k | 376k | 1.90 |
| 2024-09-30 | $360k | 273k | 1.32 |
| 2024-06-30 | $74k | 73k | 1.02 |
| 2024-03-31 | $384k | 210k | 1.83 |
| 2022-03-31 | $61k | 84k | 0.72 |
| 2021-12-31 | $643k | 285k | 2.26 |
| 2021-09-30 | $542k | 188k | 2.88 |
| 2021-06-30 | $642k | 169k | 3.79 |
| 2021-03-31 | $804k | 237k | 3.39 |
| 2020-12-31 | $458k | 164k | 2.80 |
| 2020-09-30 | $463k | 185k | 2.51 |
| 2020-06-30 | $1.9M | 136k | 13.59 |
| 2020-03-31 | $1.1M | 145k | 7.58 |
| 2019-12-31 | $1.1M | 173k | 6.32 |
| 2019-09-30 | $492k | 125k | 3.93 |
| 2019-06-30 | $655k | 135k | 4.84 |
| 2019-03-31 | $917k | 112k | 8.20 |
| 2018-12-31 | $55k | 10k | 5.40 |
| 2018-09-30 | $840k | 95k | 8.84 |
| 2018-06-30 | $148k | 15k | 10.02 |
| 2018-03-31 | $297k | 31k | 9.53 |
| 2017-12-31 | $268k | 18k | 14.88 |
| 2017-09-30 | $30k | 1.6k | 19.25 |
| 2017-06-30 | $0 | 14k | 0.00 |
| 2017-03-31 | $8.6k | 878 | 9.82 |
| 2016-12-31 | $43k | 4.1k | 10.49 |
| 2016-09-30 | $3.0k | 348 | 8.72 |
| 2016-06-30 | $4.0k | 493 | 8.11 |
| 2016-03-31 | $2.1k | 193 | 10.70 |
| 2015-12-31 | $7.8k | 459 | 16.95 |
| 2015-09-30 | $75k | 8.4k | 8.90 |
| 2015-06-30 | $9.2k | 523 | 17.54 |
| 2015-03-31 | $5.1k | 474 | 10.72 |
| 2014-12-31 | $4.0k | 445 | 8.99 |
| 2014-09-30 | $2.0k | 81 | 24.69 |
| 2014-06-30 | $67k | 2.5k | 26.85 |